- Home
- DTIL vs PMVP Comparison
DTIL vs PMVP Comparison
Compare DTIL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- PMVP
- Stock Information
- Founded
- DTIL 2006
- PMVP 2013
- Country
- DTIL United States
- PMVP United States
- Employees
- DTIL N/A
- PMVP N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- DTIL Health Care
- PMVP Health Care
- Exchange
- DTIL Nasdaq
- PMVP Nasdaq
- Market Cap
- DTIL 55.3M
- PMVP 62.3M
- IPO Year
- DTIL 2019
- PMVP 2020
- Fundamental
- Price
- DTIL $4.96
- PMVP $1.48
- Analyst Decision
- DTIL Strong Buy
- PMVP Strong Buy
- Analyst Count
- DTIL 2
- PMVP 1
- Target Price
- DTIL $47.00
- PMVP $5.00
- AVG Volume (30 Days)
- DTIL 84.3K
- PMVP 231.0K
- Earning Date
- DTIL 08-07-2025
- PMVP 08-07-2025
- Dividend Yield
- DTIL N/A
- PMVP N/A
- EPS Growth
- DTIL N/A
- PMVP N/A
- EPS
- DTIL N/A
- PMVP N/A
- Revenue
- DTIL $1,261,000.00
- PMVP N/A
- Revenue This Year
- DTIL N/A
- PMVP N/A
- Revenue Next Year
- DTIL $135.19
- PMVP N/A
- P/E Ratio
- DTIL N/A
- PMVP N/A
- Revenue Growth
- DTIL N/A
- PMVP N/A
- 52 Week Low
- DTIL $3.61
- PMVP $0.81
- 52 Week High
- DTIL $11.09
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- DTIL 56.59
- PMVP 54.76
- Support Level
- DTIL $4.55
- PMVP $1.42
- Resistance Level
- DTIL $4.99
- PMVP $1.60
- Average True Range (ATR)
- DTIL 0.32
- PMVP 0.10
- MACD
- DTIL 0.02
- PMVP -0.01
- Stochastic Oscillator
- DTIL 81.11
- PMVP 43.48
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.